PAMU
APTO

Pictet Asset Management (UK)’s Aptose Biosciences, Inc. APTO Stock Holding History

Pictet Asset Management (UK)’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,977
Closed -$16.1M – 1868
2021
Q1 		$16.1M Sell
5,977
-2,747
-31% -$5.45M 0.02% 551
2020
Q4 		$17.2M Hold
8,724
– – 0.02% 511
2020
Q3 		$23.4M Buy
8,724
+2,306
+36% +$5.75M 0.04% 408
2020
Q2 		$18.1M Buy
6,418
+2,886
+82% +$9.31M 0.03% 411
2020
Q1 		$9.16M Buy
+3,532
New +$10.5M 0.02% 499

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Pictet Asset Management (UK)'s APTO Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Aptose Biosciences, Inc. (APTO) in Q2 2021, closing a stake of 5,977 shares — an estimated $16.1M sold.

Pictet Asset Management (UK) first reported a position in APTO in Q1 2020 and held it in 5 quarters. The position peaked at $23.4M in Q3 2020. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.

  • Pictet Asset Management (UK) reported no remaining Aptose Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 5,977 Aptose Biosciences, Inc. shares in Q2 2021, an estimated $16.1M.
  • Pictet Asset Management (UK) first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 5 quarters.
  • Pictet Asset Management (UK)'s Aptose Biosciences, Inc. position peaked at $23.4M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.